Retension Pharmaceuticals Inc. Company Profile
NASDAQ: RTSNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 12, 4:00 PM ET · Delayed 15 min
After hours: 11.30 -0.18%
Retension Pharmaceuticals at a glance
Retension Pharmaceuticals Inc. (NASDAQ: RTSN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Falls Church, VA. Retension Pharmaceuticals employs about 12 people. The company's shares have traded publicly since 2026.
At a market capitalization of $89.2 million, it is considered a small-cap company.
Summary generated from market data by MetaCap's automated system. Methodology
What does Retension Pharmaceuticals do?
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Business description based on the company's public filings.
Company information
- Legal name
- Retension Pharmaceuticals Inc.
- Ticker
- NASDAQ: RTSN
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 12
- Headquarters
- 1104 West Broad Street, Falls Church, VA, United States
- Phone
- (703) 940-9761
- Website
- retensionpharmaceuticals.com
- IPO year
- 2026
- Market cap
- $89.22M
Companies similar to Retension Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RLYBRallybio Corporation | 16.79 | -1.35% | $89.20M | vs RTSN |
| QUCYQuantum Cyber N.V. | 1.03 | -23.70% | $86.59M | vs RTSN |
| CTORCitius Oncology Inc. | 0.8126 | -3.24% | $85.94M | vs RTSN |
| PMNProMIS Neurosciences Inc. | 9.45 | -1.66% | $84.74M | vs RTSN |
| EQEquillium Inc. | 1.50 | +6.38% | $95.11M | vs RTSN |
| ACRVAcrivon Therapeutics Inc. | 1.90 | -0.52% | $81.42M | vs RTSN |
| AARDAardvark Therapeutics Inc. | 4.45 | -6.51% | $97.39M | vs RTSN |
| TELOTelomir Pharmaceuticals Inc. | 1.10 | -1.79% | $80.98M | vs RTSN |